OCULOcular Therapeutix, Inc.
$7.53-38% 1Y
$7.53
$6.8852 weeks$16.11
Is the price fair?
What OCUL's price assumes
Ocular Therapeutix, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 42.2× revenue.
42.2
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 4.22
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 4.22
- EV / EBIToperating margin −603%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $2.14B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks